Recently, N-3 PUFAs have been reported to increase the number of CD4+CD25+Foxp3+Treg cells[11, 33–36] and to decrease Th17 cell differentiation and IL-17 production in other disease models including encephalomyelitis and psoriasis [36–38]. Here, IL17A is linked to encephalomyelitis.